CVS Group Continues Share Buyback, Cutting Share Count Further
CVS Group plc ( (GB:CVSG) ) just unveiled an announcement.
CVS Group plc, a major veterinary services provider in the UK and Australia, offers clinical care through hundreds of practices alongside diagnostic laboratories and its Animed Direct online retail arm. The company’s workforce of about 9,000 includes 2,500 veterinary surgeons and 3,300 nurses, underlining its scale in small-animal healthcare.
The company has repurchased 138,695 ordinary shares between 21 and 25 September 2026 as part of its ongoing share buyback programme and intends to cancel all of these shares. Following this latest tranche, CVS will have 67,476,802 shares in issue and has bought back a total of 2,686,297 shares under the programme, reducing its share count and potentially enhancing earnings per share for existing investors.
The most recent analyst rating on (GB:CVSG) stock is a Hold
with a £1400.00 price target.
To see the full list of analyst forecasts on CVS Group plc stock,
see the GB:CVSG Stock Forecast page.
Spark’s Take on CVSG Stock
According to Spark, TipRanks’ AI Analyst, CVSG is a Neutral.
The score is primarily held back by only moderate financial quality (thin/volatile net profitability, higher 2026 leverage, and weaker free cash flow) and weak technicals (below key moving averages with negative MACD). Elevated valuation (high P/E with low yield) further reduces the overall attractiveness.
To see Spark’s full report on CVSG stock,
click here.
More about CVS Group plc
CVS Group plc is a leading provider of veterinary services operating in the UK and Australia and listed on the Main Market of the London Stock Exchange. The Group runs more than 475 veterinary practices, including specialist referral hospitals and out-of-hours sites, and also operates laboratories and the Animed Direct online retail business, employing around 9,000 staff.
Average Trading Volume: 255,456
Technical Sentiment Signal: Sell
Current Market Cap: £816.8M
See more data about CVSG stock on TipRanks’ Stock Analysis page.
